First-in-Human gene therapy tested for blinding eye disease
Disease control
Not yet recruiting
This is a very early study to check if a new gene therapy called UGX202 is safe for people with advanced retinitis pigmentosa (RP), a disease that causes severe vision loss. Six patients with very low vision will receive a single injection of the therapy into one eye and be monit…
Phase: EARLY_PHASE1 • Sponsor: Suzhou UgeneX Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC